para-Bromoamphetamine
para-Bromoamphetamine (PBA), also known as 4-bromoamphetamine (4-BA), is an amphetamine derivative which acts as a serotonin-norepinephrine-dopamine releasing agent (SNDRA) and produces stimulant effects.
![]()  | |
![]()  | |
| Clinical data | |
|---|---|
| ATC code | 
  | 
| Legal status | |
| Legal status | |
| Identifiers | |
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C9H12BrN | 
| Molar mass | 214.106 g·mol−1 | 
| 3D model (JSmol) | |
  | |
  | |
|   | |
Neurotoxicity
    
Like most other para-substituted amphetamines, PBA can be neurotoxic and may deplete the brain of 5-hydroxyindoles for at least a week.[1]
See also
    
- Substituted amphetamines
 - 4-Bromomethcathinone (4-BMC)
 - 4-Fluoroamphetamine (4-FA)
 - para-Chloroamphetamine (PCA)
 - para-Iodoamphetamine (PIA)
 
References
    
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

